Science & Research During  the COVID-19 Crisis


This is an incredibly challenging and difficult time for autism scientists.  The COVID-190 emergency is dramatically affecting research efforts. Universities across the country are shuttered, and many research projects have significantly altered, slowed or stopped for at least the next month.  We are grateful for the dedication and creativity we have seen from the autism research community to ensure that research discoveries continue in some way, and we are committed to helping researchers continue to pursue these efforts. We are also eager for investigators to pursue new lines of inquiry that may now be appropriate during this time of unprecedented change, including studies focused on tele-medicine and tele-therapy.   

We have compiled a list of resources specifically to help support scientists and researchers.  It includes webinars, ideas from experts, resources from industry and universities, and responses from other funding agencies.  This list will be constantly updated so keep checking back.  You can access it   here .

For Fellows and Trainees

ASF and Autism Speaks are hosting a Research Regroup Webinar on April 1st at 1pm EST for autism research fellows to help share challenges, ideas, and potential solutions for slowing or stoppage of research studies in autism during the COVID-19 emergency. Register  here.

NIH and CDC policies and grant opportunities

The CDC has shared flexibilities available to applicants and recipients of Federal financial assistance affected by COVID-19  here

The National Science Foundation published a list of resources, including possible funding opportunities to understand COVID-19.

Advice for Scientists

Inside Higher Ed  is sharing live updates on how higher education is reacting to the new coronavirus pandemic, including research and grant protocols. To view their live feed click  here .

The Center for Undergraduate Research  c ompiled a list of online tools, advice and virtual events. If you have problems access any one of these tools, email ahalladay@autismsciencefoundation.org

Technology and other resources

Craig Lipset, former Head of Clinical Innovation at Pfizer, has compiled a 

Researchers in academia conducting clinical trials or clinical research may also find these helpful. They include trusted technology platforms and devices.

Coming Soon

Dr. David Mandell, ASF Scientific Advisory Board member and Professor and Director at the  Penn Center for Mental Health , will provide guidance for shutting down studies while keeping up services delivery.



Do you have a resource you would like to share? Email us at  contactus@autismsciencefoundation.org

STAY CONNECTED: